GENERAL COMMENTS
In the present paper, the authors aimed to compare outcomes and quality of secondary prevention in post-MI patients from 3 different countries (Switzerland, Poland, Ukraine) based on data from 3 tertiary care teaching hospitals. The primary endpoint was all cause mortality at 3.5 years of follow up. The paper is interesting and well written but suffers from some important weaknesses.
patients (54%). A loss of follow-up of 46% of patients must be explained in details and constitutes another strong limitation of this study.
3. Important part of ACS were STEMI but this proportion was very different between the 3 centers. In Bern, 50.6% of ACS were STEMI while this proportion was approximatively 75% in Gdansk and Lutsk. It could highly contribute to the better prognosis of patients from Bern (as they had less STEMI patients). Comparing outcomes of unstable angina/NSTEMI patients with STEMI patients may not be appropriate and sub-groups analyses should be performed. 4. Only Table 1 provides p values for each line. In Table 4 and 5, authors should provide these values and not only as a comment (for a few lines only) in the legends of the table.
5. A multivariate analysis seems to be obligatory before affirming which parameter impacted the prognosis. Indeed, authors affirm that the two most important differences between the countries leading to this striking differences in total mortality are most probably the number of patients treated with PCI in the acute phase and the lack of insurance coverage during follow-up. However, no statistical test defends this hypothesis. Is it unclear if the insurance coverage plays any role to explain the highest mortality with a rate of reperfusion that is so different.
In summary, it seems that this study illustrates that lower rates or reperfusion is associated with a higher mortality but the demonstration of an impact of socioeconomic factor (as suggested by the title) and the generalization in between-countries differences is not possible based on these data. Minor : 1. Authors should precise clearly the total number of included (547 patients in Switzerland + 375 in Poland + 164 in Ukraine). 2. Table 1 : Columns titles : Authors named the columns with a mix of cities (Bern) and countries (Poland and Ukraine).
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GENERAL COMMENTS
Review of the paper entitled: Outcomes after Myocardial Infarction in Different Socioeconomic Environments Manuscript ID: bmjopen-2016-012715 The authors are evaluating the long-term impact of socioeconomic environments on outcomes after a first acute myocardial infarction.
Major criticism This study is very interesting but there are some important issues about the statistics. The authors should have had p-values in tables 4 and 5. Moreover, they should have had a multivariate analysis to measure the weight of the socioeconomic environments on outcomes compared to other risk factors. In fact, this multivariate analysis would have help to explain the significantly higher mortality in Poland and Ukraine compared to Switzerland. Without such analysis, I do not agree with this sentence in the discussion: "Although we found some differences in baseline characteristics, they fail to fully explain the striking gap in mortality between our three study areas." The study is not design to answer or say this affirmation. Re-hospitalization for cardiovascular disease was named as secondary study endpoint, but no results were presented in the paper! The data on secondary outcomes seem to be only patient-reported and not validated by other sources. This a limitation and should be mentioned in the discussion Page 7: Table 1: • Please replace "Bern" by "Switzerland" and add total number of patients in each county • How was smoking defined (current, former ?) • Please replace DM by diabetes mellitus • How was obesity defined?
• The reported number of cases for each variable shows that there is missing information, e.g. there is significant missing information on renal and lung disease, and cancer in the Ukraine. Please also clarify why information on STEMI is missing in a number of patients from Poland.
• I think it is not necessary to show the p-values for the comparison between each single hospital (last three columns) Page 8: Table 2 : Please add the data source. Page 9: Table 4 indicates that 100% of the included patients in Switzerland received a PCI. I would have expected a high number as the hospital is a University hospital, but in a sample with almost 50% NSTEMI patients it is more than surprising that all patients received PCI. Please comment on this by referring to other research that provides PCI rates in Switzerland. Table 5 : For a large number of patients information on medication is missing (e.g. about 45% of the patients in Poland!). Response rates in each country should be added to the results section. Discussion: The authors should be careful when discussing literature on the association between socioeconomic status and mortality. In their study the socioeconomic status was only estimated on a country level whereas in other studies such as Rosvall et al. socioeconomic status was assessed on the individual level. I"m not quite sure that this study which uses single hospitals provides more reliable results that studies based on AMI registries which include several hospitals within a defined study region. Clearly, the chosen study approach is missing external validity. As discussed by the authors, specifically the situation in the Ukraine indicates that the selected study hospital may not be representative for the treatment situation in this respective country.
Conclusion:
The authors conclude that the mortality differences cannot be explained by different risk factor profiles or comorbidities and are probably mainly due to the different socioeconomic situation. I believe this conclusion is too strong, because the authors did not statistically analyze the contribution of risk factor/comorbidity differences to survival. I the same way one could conclude that missing PCI treatment in the Ukraine contributes to most of the survival differences. To support such conclusions it is not sufficient to rely on descriptive statistics, but further multivariable analyses are needed. This study only provides some hints, which country differences may be relevant for AMI outcomes.
The conclusion in the abstract should also be modified.
VERSION 1 -AUTHOR RESPONSE
-Please revise your title to indicate the research question, study design, and setting. This is the preferred format of the journal. We adapted the title as follows: Long-term Outcomes after Acute Myocardial Infarction in countries with Different Socioeconomic Environments: An International Prospective Cohort Study . -In the "Article Summary" section of your manuscript, please present your key strengths and limitations in list form. Please remove the sections "What is already known about this subject," "What does this study add," and "How might this impact on clinical practice," as these are not part of the journal format.
-We added comments in regard to key strengths and limitation and removed the sections as requested.
-Key strengths of this study are -its prospective design comparing original data from patients in three distinctly different socioeconomic environments, -the fact that our results are based on a direct comparison between single hospitals with similar service population, similar compliance to guidelinerecommended therapies and comparable research activities, but acting under three different economic situations, whereas interventions and outcome after ACS are usually compared in the framework of registry studies including single or various hospitals within countries (without clear definition of the catchment area and no convincing indication that the selected hospital population would be representative for the whole country).
-Limitations of this study are -the fact that extrapolation of such local results to a whole country has still to be performed with caution, -that we used information about the socioeconomic situation only on an region/country level but not on an individual level, -that secondary outcomes are only patientreported and not validated by other sources -that the reliability of the data in regard to medication and cardiac rehabilitation is somewhat compromised by the fact, that a limited number of patients did not answer the follow-up questionnaire and could not be reached by telephone for an interview.
very similar medical services and identical insurance situation), and most likely true also for Gdansk/Poland (representative demographic and socioeconomic situation of the service polulation, one national insurance payer covering costs of all MIs in public and private hospitals with identical sets of procedures and requirements and similar results of recent outcome analyses performed in the years 2009-2014 by the National Institute of Public Health with small differences in 1-and 3-year mortality between the reference university hospitals. However, for Lutsk, the comparison is more complicated for Ukraine, being a country in transition typically with greater fragmentation within the country. In 2010 however, when patients entered this study, Ukraine had only 25 PCI/1 million inhabitants in comparison to 506 (Switzerland) and 735 (Poland)/1 million inhabitants; as the number for PCI"s in Ukraine has been very small overall, it seems unlikely that this has led to important differences in ACS mortality between different regions of Ukraine, perhaps with the exception of somewhat lower mortality in the capital city Kiev. Nevertheless, after 2010 the number of PCI"s increased steadily and substantially, which can be seen in the context of the "stent for life" initiative. 3. In table 4, 375 primary PCI were done in Poland but data on discharge treatment and data on follow-up are available for only 205 patients (54%). A loss of follow-up of 46% of patients must be explained in details and constitutes another strong limitation of this study. We agree. We explain and add this limitation.
4. Important part of ACS were STEMI but this proportion was very different between the 3 centers. In Bern, 50.6% of ACS were STEMI while this proportion was approximatively 75% in Gdansk and Lutsk. It could highly contribute to the better prognosis of patients from Bern (as they had less STEMI patients). We added a multivariate analysis of the outcomes related to STEMI/non-STEMI.
5. Only Table 1 provides p values for each line. In Table 4 and 5, authors should provide these values and not only as a comment (for a few lines only) in the legends of the table.
We added p values into tables 4 and 5 5. A multivariate analysis seems to be obligatory before affirming which parameter impacted the prognosis. Indeed, authors affirm that the two most important differences between the countries leading to this striking differences in total mortality are most probably the number of patients treated with PCI in the acute phase and the lack of insurance coverage during follow-up. However, no statistical test defends this hypothesis. Is it unclear if the insurance coverage plays any role to explain the highest mortality with a rate of reperfusion that is so different. In summary, it seems that this study illustrates that lower rates or reperfusion is associated with a higher mortality but the demonstration of an impact of socioeconomic factor (as suggested by the title) and the generalization in between-countries differences is not possible based on these data. We added a multivariate analysis to the statistical calculation to clarify the results and to support our conclusions. And we adapted the comments in the manuscript accordingly. . Follow-up data was obtained by patient-self report, all-cause mortality by local/national registries. Chi-square tests and one-analyses of variance were used for data analysis. Mortality was highest in Ukraine (hospital without PCI treatment), lower in Poland and the lowest mortality was found in Switzerland. Also, differences regarding secondary prevention medication and cardiac rehabilitation within the countries were found. Results on re-hospitalization were not reported. The authors concluded that the mortality difference may be mainly due to the socioeconomic situation of the different countries and that an increase of PCI treatments does not guarantee lower mortality rates. Title:
The title is not very precise. It does not include the information that the study considers long-term outcomes (which is important) and that the study sample is from different countries. So I would suggest to include this important information in the title e.g. "Long-term outcomes after AMI in countries with different socioeconomic environments".
How was this information collected? By chart review, patient interview etc.? We agree that this information is missing in the manuscript and added the following words to the Methods section/Patient and treatment characteristics: Data has been collected by a dedicated researcher in each hospital by chart review. Page 6: Re-hospitalization for cardiovascular disease was named as secondary study endpoint, but no results were presented in the paper! We apologize that we added re-hospitalizations mistakenly in the method section as secondary endpoint without integrating this parameter in our study protocol. We deleted re-hospitalization as secondary endpoint under Methods/Clinical outcomes. The data on secondary outcomes seem to be only patient-reported and not validated by other sources. This a limitation and should be mentioned in the discussion We agree with this comment and added the following sentence under limitations: Another limitation is that data on secondary outcomes are only patient-reported and not validated by other sources. Page 7: • The reported number of cases for each variable shows that there is missing information, e.g. there is significant missing information on renal and lung disease, and cancer in the Ukraine. Please also clarify why information on STEMI is missing in a number of patients from Poland. We agree that whereas the information on renal and lung disease as well as cancer is complete for Bern/Switzerland and Gdansk/Poland, data is incomplete for Lutsk/Ukraine. This is unfortunate but it is due to local particularities in the way patients history and diagnoses are recorded in Lutsk.
• I think it is not necessary to show the p-values for the comparison between each single hospital (last three columns) We did not change this because even more p-values have been requested by reviewer 1. However, we leave the final decision on this up to the editor. Page 8: Table 2 : Please add the data source. We added data sources for the three countries. Page 9: Table 4 indicates that 100% of the included patients in Switzerland received a PCI. I would have expected a high number as the hospital is a University hospital, but in a sample with almost 50% NSTEMI patients it is more than surprising that all patients received PCI. Please comment on this by referring to other research that provides PCI rates in Switzerland. We apologize that we added an incorrect number in this table. As indicated in the manuscript, the correct number is 98%. There is a policy that all acute MI undergo emergency angiography and if necessary emergency PCI irrespective of the MI being STEMI or non-STEMI. The high percentage of 98% is correct for the Swiss Cardiovascular Center in Bern being the largest Cardiovascular Center in Switzerland with the by far most active interventional cardiology department. The respective number in table 4 has been corrected from 100% to 98%. Table 5 : For a large number of patients information on medication is missing (e.g. about 45% of the patients in Poland!). Response rates in each country should be added to the results section.
Unfortunately, response rates for this follow-up evaluation have been incomplete which has been expected and led to the decision to have the information on medication only as secondary endpoint. Furthermore, we state incomplete response rate as a limitation at the end of the discussion. We added the response rates to the numbers. Discussion: The authors should be careful when discussing literature on the association between socioeconomic status and mortality. In their study the socioeconomic status was only estimated on a country level whereas in other studies such as Rosvall et al. socioeconomic status was assessed on the individual level.
We agree with this comment. However, we expect that the average socio-economic situation in the three distinctly different patient populations does not significantly differ from the average socioeconomic situation in the region/the country. We added a statement to the section on limitations: Another limitation is that we used estimates of socio-economic situation only on an area/country level but not on an individual level. I"m not quite sure that this study which uses single hospitals provides more reliable results that studies based on AMI registries which include several hospitals within a defined study region. Clearly, the chosen study approach is missing external validity. As discussed by the authors, specifically the situation in the Ukraine indicates that the selected study hospital may not be representative for the treatment situation in this respective country. As previously indicated in our reply to point 2. of this reviewer, we explained, to which extent the catchment areas of the three select hospitals are representative for the whole population in the respective country in the discussion Conclusion:
The conclusion in the abstract should also be modified.Introduction
Page 4, line 30: Please add an "s" to outcome. done Results Table 3 : Please add more details about the calculation of population density of catchment area since I would have thought that Ukraine would have had the lowest? We added some additional comments in regard to potential differences between the three service areas and service populations. Page 9, line 42: As mentioned previously, please add p-values so your sentence would be credible.
We added p-values as requested Page 10, line 12: When mentioning this "In Poland there was a slight but clinically significant decrease in the use of antiplatelets, statins, ACEIs or ARBs…" please add a statistical test and the corresponding p-value to understand this affirmation. We did additional statistical testing and added corresponding p-value Page 10, line 15: Please explain to me why 78.2% is considered half when mentioning this "In Ukraine drug use decreased drastically: at follow-up only half of all patients were treated with antiplatelets and also the use of statins…"? In this sentence again, please correct the world "als0" by "also". We added results of statistical testing and corrected the word "also" Discussion Page 11, line 35: Please add some nuance in this sentence: "Although we cannot exclude differences in acute intervention times and also in procedural success rates between the two countries as a contributing factor (because this has not been evaluated in this study population), this finding underlines the importance of secondary prevention…" It is important to add that other baseline risk factors may have played a role. You would have needed a multivariate analysis to confirm this. Multivariate analysis has been performed and a respective comment on the importance of comorbidities and baseline risk factors for prognosis has been added. Page 12, line 17: Again which tests you did to mention that you found some differences in baseline characteristics but they failed to fully explain the striking gap in mortality? As stated previously, we added results from multivariate testing to substantiate our statements in regard to baseline characteristics. Page 13, line 32: When mentioning only 78.2% of patients were on antiplatelets, this seem strange to me. May be you should add compare to … Moreover, please correct 78,2% for 78.2%. We corrected the sentence and "78.2" accordingly Page 14, line 45: The first sentence of the conclusions should be divided in two please or add two points. We divided the first sentence of the conclusions in two sentences. Figure  Please correct in the title of the figure the world year since it is written "yeaer". done
